Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study

Uveal melanoma is the second most common melanoma and the most common intraocular malignant tumour of the eye. Among various treatments currently studied, Sorafenib was also proposed as a promising drug, often administered with other compounds in order to avoid resistance mechanisms. Despite its pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonaccorso, Angela, Pepe, Veronica, Zappulla, Cristina, Cimino, Cinzia, Pricoco, Angelo, Puglisi, Giovanni, Giuliano, Francesco, Pignatello, Rosario, Carbone, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622456/
https://www.ncbi.nlm.nih.gov/pubmed/34834371
http://dx.doi.org/10.3390/pharmaceutics13111956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622456/
https://www.ncbi.nlm.nih.gov/pubmed/34834371
http://dx.doi.org/10.3390/pharmaceutics13111956

Ejemplares similares